Schedule 13G ownership disclosure

Upstream Bio Inc

Common Stock, par value $0.001 per share · CUSIP: 91678A107

Event date: 2026-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Decheng Capital Global Life Sciences Fund IV, L.P.

    Shares: 2,724,868.00 · Class: 4.9%

  • Decheng Capital Management IV (Cayman), LLC

    Shares: 2,724,868.00 · Class: 4.9%

  • Xiangmin Cui

    Shares: 2,724,868.00 · Class: 4.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001834150-26-000006
Form type
SCHEDULE 13G/A
Filer
Upstream Bio, Inc.
CIK
CIK 2022626
Filed
Oct 29, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub